Commentary: Anatomical partial lobectomy: The indications should be better defined

Affiliations

¹ Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institute of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
² Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institute of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: hqchen1@yahoo.com.

Free article

Editorial

Yang Zhang et al. J Thorac Cardiovasc Surg. 2022 Sep.

Free article

. 2022 Sep;164(3):648-649.

doi: 10.1016/j.jtcvs.2021.11.033. Epub 2021 Nov 20.

¹ Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institute of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
² Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institute of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: hqchen1@yahoo.com.

No abstract available

Comment on

Outcomes and experience of anatomical partial lobectomy.
Qiu B, Ji Y, Zhang F, Bai G, Xue Q, Polaczek M, Tosi D, Koike T, Gao S, He J. Qiu B, et al. J Thorac Cardiovasc Surg. 2022 Sep;164(3):637-647.e1. doi: 10.1016/j.jtcvs.2021.11.044. Epub 2021 Nov 26. J Thorac Cardiovasc Surg. 2022. PMID: 35074181